Which Cancers Can Be Treated with Lutetium 177 Therapy?
Lu-177 therapy is primarily used in the treatment of neuroendocrine tumors and metastatic castration-resistant prostate cancer (mCRPC). The therapy has shown significant promise in patients with advanced stages of these cancers, providing an alternative when conventional treatments like surgery, chemotherapy, or radiation have failed.
